Recent Finacing
Recent Raise
Oligomerix is a clinical-stage biotechnology company developing oral small-molecule inhibitors, antibody therapeutics, and biomarkers targeting tau oligomers and proteolytic activity for Alzheimer’s disease and related tauopathies.
